Oncology & Hematology Specialists

Having specialized in oncology & hematology for over 15 years, Horizon has extensive experience and a deep understanding of this diverse and increasingly complex and competitive market.

Thoracic Oncology
Thoracic Oncology
  • NSCLC (Resectable, Unresectable Stage III, Metastatic: PD-L1 high/low/negative, EGFRm, KRASm, Squamous, Non-squamous)
  • SCLC
  • Mesothelioma
Gynaecologic Oncology
Gynaecologic Oncology
  • Breast (Early, Advanced, HR+, HER2+, TNBC, BRCAm, PIK3CAm, HER2-low)
  • Ovarian (1L, PSR, Platinum Resistant)
  • Endometrial
  • Cervical
GI Oncology
GI Oncology
  • CRC (Resectable, Unresectable: RASm, RAS WT)
  • HCC (Intermediate, Advanced)
  • Gastric (Locally advanced, Metastatic)
  • Pancreatic
  • Biliary Tract (IHCC, EHCC, Hilar, Gallbladder, Ampullary)
  • GIST
GU Oncology
GU Oncology
  • Prostate (Early, BCR, mCSPC, mCRPC)
  • Bladder (NMIBC, MIBC, Advanced)
  • RCC (Clear Cell, Papillary)
Other Solid Tumors
Other Solid Tumors
  • HNSCC
  • Melanoma (Cutaneous, Uveal)
  • Pilocytic Astrocytoma
  • NF-1
Hematology
Hematology
  • Multiple Myeloma
  • CLL
  • NHL (DLBCL, FL, MCL, PTCL)
  • AML
  • MDS
  • IMF & PV
Diagnostics
Diagnostics
  • Screening (NSCLC, CRC)
  • Genetic testing (BRCA, NF-1)
  • Gene panel testing provision
  • PD-L1 testing (logistics, standardization)
  • HER2 testing (approach, HER2-low)
  • Companion diagnostics (PD-L1, MSI/dMMR, BRCA, HRD, HER2, EGFR, RAS, BRAF, MET, PIK3CA, FGFR)
Supportive Care
Supportive Care
  • CIA
  • Bone mets
  • Pain
  • Opioid induced constipation
  • CINV and RINV